ALKEON CAPITAL Overview
Alkeon Capital Management is a hedge fund that manages 4.8 BN dollars in regulatory AUM and has 31 employees, of which 12 perform investment advisory functions.
The manager's has disclosed holdings from 12/31/02 to 06/30/20. The fund's latest filing disclosed 19BN in positions, representing 395% of the manager's regulatory AUM.
The manager's has disclosed holdings from 12/31/02 to 06/30/20. The fund's latest filing disclosed 19BN in positions, representing 395% of the manager's regulatory AUM.
ALKEON CAPITAL StockAlpha
| Top 25% |
3yr StockAlpha
Register for more...
Fundamental & Technical Factor Exposure
ALKEON CAPITAL Since Last Filing Return Details
| Ticker | Size | Sector | Stock Move | StockAlpha Attribution | Days to Liquidate | Trade Crowdedness | ||
|---|---|---|---|---|---|---|---|---|
| RNG | 5.52% | Telecom | -0.75% | -0.68% | 2 | 11% | ||
| AMZN | 4.08% | Cons. Disc. | 16.25% | -0.04% | 0 | 47% | ||
|
Unlock Positions and Returns Details |
||||||||
FEATURED IN
ALKEON CAPITAL Founders and Key Employees
| Name | Title | In Position Since |
|---|
| Panayotis D. Sparaggis | Managing Director | November-2001 |
| Gregory D. Jakubowsky | Chief Operating Officer/Chief Compliance Officer | February-2006 |
| George Mykoniatis | Chief Financial Officer | February-2006 |
| Jennifer W. Shufro | Managing Director Of Legal And Compliance | July-2013 |
| Andrew T. Arnedt | General Counsel | March-2011 |
ALKEON CAPITAL Brokers, Custodians, Auditors and Administrators
| Type | Company |
|---|
| Administrator | Pro |
| Administrator | Pro |
| Auditor | Pro |
| Custodian | Pro |
| Custodian | Pro |
| Custodian | Pro |
| Custodian | Pro |
| Prime Broker | Pro |
| Prime Broker | Pro |
ALKEON CAPITAL Investment Strategy
Methods of Analysis, Investment Strategies and Risk of Loss
Investment Strategy
Alkeon’s investment objective for all of the funds it manages generally is to achieve capital appreciation by investing primarily in long or short positions of publicly-traded and private companies across sectors globally. Alkeon will seek to generate absolute returns by investing in the securities of companies that can provide positive returns relative to the general equity securities market.
Alkeon provides advisory or sub-advisory services to its clients using the general strategy described above except that (a) the Alkeon Growth Funds, the OAM Funds, ALPRO Growth, and MS UCITs primarily invest in long and short positions of global growth stocks; (b) the Alkeon Select Funds invest primarily in long positions of global growth stocks; (c) the Alkeon Asia Growth Funds invest primarily in long and short positions of global growth stocks based in the Asia Pacific region...
Unlock Full Investment Process Description
Investment Strategy
Alkeon’s investment objective for all of the funds it manages generally is to achieve capital appreciation by investing primarily in long or short positions of publicly-traded and private companies across sectors globally. Alkeon will seek to generate absolute returns by investing in the securities of companies that can provide positive returns relative to the general equity securities market.
Alkeon provides advisory or sub-advisory services to its clients using the general strategy described above except that (a) the Alkeon Growth Funds, the OAM Funds, ALPRO Growth, and MS UCITs primarily invest in long and short positions of global growth stocks; (b) the Alkeon Select Funds invest primarily in long positions of global growth stocks; (c) the Alkeon Asia Growth Funds invest primarily in long and short positions of global growth stocks based in the Asia Pacific region...
Unlock Full Investment Process Description
ALKEON CAPITAL Portfolio Concentration
ALKEON CAPITAL Location
350 MADISON AVENUE
9TH FLOOR
NEW YORK, New York
UNITED STATES, 10017
9TH FLOOR
NEW YORK, New York
UNITED STATES, 10017
ALKEON CAPITAL Contact Information
Phone Number: 212-716-6570
Fax Number: 646-514-2237
Website: http://www.alkeoncapital.com
Fax Number: 646-514-2237
Website: http://www.alkeoncapital.com
READ RECENT SYMMETRIC REPORTS
Disclaimer
The information contained herein: (1) is proprietary to Symmetric and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Symmetric nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance and skill metrics are no guarantee of future results. "Symmetric," "Symmetric.io" and the Symmetric logo are marks of Symmetric, Inc. Read our privacy policy here. Read our terms of use here